–
December 2, 2026
Upcoming: In the Room: Understanding Clinical Trials: What Every Parent Should Know
December 2, 2026 7:00 pm
TO REGISTER: https://courageousparentsnetwork.org/events/in-the-room-understanding-clinical-trials-what-every-parent-should-know/
About
For many families caring for a child with medical complexity, the words “clinical trial” carry both hope and a lot of questions, and the process can feel confusing, restrictive, or out of reach. Join us In the Room as we demystify clinical research, starting with how it differs from standard medical care and innovative treatments, and walking through key terms like randomized, blinded, placebo, arms, and endpoints, along with the different types of trials. We’ll explore why protocols, endpoints, and efficacy measures exist (even when they feel limiting or keep a child from enrolling), how regulators decide a treatment is “safe and effective enough,” and what it means when a therapy is given once versus on an ongoing basis. We’ll also look honestly at the ethical questions behind trials, from why placebos are used and investigational products are restricted outside of studies to the ongoing inequities in who hears about trials, who can realistically take part, and where and how research is conducted around the world.
Parents will leave better equipped to ask informed questions, weigh opportunities, and partner with their child’s care team when clinical research becomes part of the conversation.
Note: Clinical trial policy and practice is not static; rather, they can, and do, change over time. This presentation will be up to date at the time of its recording.
This event will take place on Wednesday, December 2 at 7:00 pm ET (6:00 pm CT, 5:00 pm MT, 4:00 pm PT).
Learning Objectives:
- Explain key clinical trial terms and how research differs from standard care.
- Describe the scientific, regulatory, and ethical reasons behind trial design and eligibility limits.
- Identify inequities in trial access and strategies to support families’ informed decision-making.